No Data
Express News | "Top-tier" fund managers frequently appear! These companies are receiving attention.
zhejiang wolwo bio-pharmaceutical (300357): steady growth in performance with continuous expansion of the pipeline under research.
Event: The company released the third quarter report of 2024, achieving an income of 0.73 billion yuan in the first three quarters of 24 years ago (+8.4%), net income attributable to the parent company of 0.27 billion yuan (+0.8%), and non-net income attributable to the parent company of 0.26 billion yuan (+0.3%).
Express News | The latest holdings of the social security fund have been exposed, with 31 new positions added.
Zhejiang Wolwo Bio-Pharmaceutical's Q3 Profit Rises 1%
Obu Biotech: Report for the third quarter of 2024
zhejiang wolwo bio-pharmaceutical (300357.SZ) profit distribution plan for the first three quarters of 2024: proposed dividend of 1 yuan per share.
GeLongHui October 23rd | Zhejiang Wolwo Bio-pharmaceutical (300357.SZ) announced that in order to actively reward the vast number of investors, considering the funds needed for the company's sustainable development in the future and the reasonable return to investors, the profit distribution plan for the first three quarters of 2024 was determined at the ninth meeting of the fifth board of directors. Based on the total share capital of 523,584,000 shares of the company as of September 30, 2024, the company will distribute cash dividends of 1.00 yuan (tax included) per 10 shares to all shareholders, totaling cash dividends of 52,358,400.00 yuan (tax included), without bonus shares, and no capital
No Data
No Data